Qual é o preço para Brickell Biotech, Inc. (BBI)

O preço para Brickell Biotech, Inc. (BBI) é $2.35

Qual é a capitalização de mercado para Brickell Biotech, Inc. (BBI)

A capitalização de mercado para Brickell Biotech, Inc. (BBI) é $162.94K

Histórico de Preços de Brickell Biotech, Inc. (BBI)

Brickell Biotech, Inc. is a pharmaceutical company currently in the clinical development phase, dedicated to creating prescription medicines for various debilitating conditions, including autoimmune and inflammatory disorders, primarily within the United States. Its product pipeline includes sofpironium bromide, which has successfully finished Phase III clinical trials for treating excessive underarm sweating (primary axillary hyperhidrosis). Other notable candidates are BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent stimulator of interferon genes (STING) inhibitor, being explored for autoinflammatory and rare genetic illnesses. The company is also advancing next-generation kinase inhibitors. Brickell Biotech collaborates with several partners, such as Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. Established in 2009, its main office is located in Boulder, Colorado.

Ano	Desempenho
2022	-80.40%
2021	-62.42%
2020	-56.44%
2019	0.00%

Ano

Desempenho

2022

-80.40%

2021

-62.42%

2020

-56.44%

2019

0.00%

Empresa	Preço da ação	Variação 1a%	País
Vertex Pharmaceuticals Incorporated VRTX.US	$517.18	30.63%	US
Argenx SE ARGX.US	$857.76	32.66%	NL
Lonza Group AG LONN.SW	$744.96	8.94%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.08K	-6.68%	KR
UCB S.A. UCB.BR	$259.89	16.65%	BE

Empresa

Preço da ação

Variação 1a%

País